Superbugs and Superdrugs 2021

Key Topics

• Controlling the use of new antibiotics
• Antibody based strategies
• The latest treatment for Hepatitis C
• Horizons for antimicrobial resistance (AMR)
• Research and development in neglected diseases
• Public/private partnerships and how you can benefit from it
• Regulatory aspects of for new antimicrobials
• Nanoparticles approach to treat Gram-Positive and Gram-Negative pathogens
• Alternative models for tackling antimicrobial resistance

Who should Attend

Attendees responsible for medical microbiology, research, clinical development, antimicrobial therapeutics and business development, including:

• Senior Vice Presidents
• Chief Scientific Officers
• Research Scientists
• Chief Medical Officers
• R&D Project Managers
• Clinical Microbiologists
• Clinical Trials Managers
• Heads of Anti-Infectives Discovery
• Senior Vice Presidents of R&D
• Principal Scientists
• Product Managers
• Business Development Managers